Ethnic specific differences in endocrine neoplasms: The role of susceptibility genes - 13/06/18
Doi : 10.1016/j.amjsurg.2017.12.005
Electron Kebebew a, b, ⁎ 
a Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
b Department of Surgery, The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA
∗Endocrine Oncology Branch National Cancer Institute Bethesda, MD 20892, USA.Endocrine Oncology Branch National Cancer InstituteBethesdaMD20892USA
Abstract |
Ethnic disparity in disease incidence, prevalence, and outcome has been documented for a variety of diseases and cancers. Dr. LaSalle D. Leffall was one of the first to note that genetic susceptibility is one important aspect that needed to be studied to better understand cancer disparity. In this article, we cover disparity in endocrine neoplasm presentation and new, emerging genetic data that may explain this disparity.
Le texte complet de cet article est disponible en PDF.Highlights |
• | In this article celebrating the work of Dr. LaSalle D. Leffall, we cover disparity in endocrine neoplasm and genetic data that may explain this disparity. |
© 2017
Publié par Elsevier Masson SAS.
Vol 215 - N° 6
P. 1060-1061 - juin 2018 Retour au numéro
Article précédent
- LaSalle D. Leffall and disparities in breast cancer
- Lori L. Wilson
- The tale of two stories: Challenges and innovations in breast cancer management
- Ronda S. Henry-Tillman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?